Fig 1: NRG3 affects osteogenic differentiation of FAPs via the PI3K/Akt signaling pathway. (A) Alizarin red staining and (B) quantification of induced osteogenic differentiation of FAPs cells in vitro. (C) Reverse transcription-quantitative PCR analysis of mRNA expression levels of RUNX2. (D) Enrichment of Kyoto Encyclopedia of Genes and Genomes pathway in transcriptome sequencing. (E) Western blotting of PI3K/Akt signaling pathway-associated (F) protein expression during osteogenic differentiation of FAPs in vitro. n=6/group. **P<0.05, ***P<0.01 and ****P<0.001. NRG3, neuregulin 3; FAP, Fibro-adipogenic progenitors; OIM, Osteogenic-inducible medium; p, Phosphorylation.
Fig 2: Peripheral nerve injury exacerbated progression of muscle HO, caused by the release of NRG3, which induced osteogenic differentiation of FAPs via the ErbB4/PI3K/Akt signaling pathway. NRG3, Neuregulin 3. HO, heterotopic ossification.
Fig 3: DeN increases secretion of NRG3. (A) Cytokine microarray analysis was used to quantify the levels of cytokine secretion in muscle heterotopic ossification. Arrow indicates the protein level of NRG3 was increased most in the CTX-DeN group compared with the CTX group. (B) Molecular interactions of NRG3. (C) Reverse transcription-quantitative PCR analysis of ErbB4 mRNA levels. n=6/group. ***P<0.005. NRG3, Neuregulin 3; CTX, Cardiotoxin; FGF, Fibroblast growth factor; TGF, Transforming growth factor; RANTES, Regulated upon activation normal T cell expressed and presumably secreted; S100A10, p11, annexin II light chain, calpactin light chain; TIMP, The tissue inhibitors of matrix metalloproteinases; DeN, Denervation.
Supplier Page from Abcam for Recombinant Human NRG3 protein (Fc Chimera)